本文選題：登革病毒　切入點(diǎn)：抗體依賴性增強(qiáng)感染　出處：《北京協(xié)和醫(yī)學(xué)院》2015年博士論文

【摘要】：登革熱病毒(Dengue virus, DENV)是一種蚊媒病毒,在超過(guò)100多個(gè)國(guó)家中,尤其是亞洲和拉丁美洲,引起了巨大的公共衛(wèi)生問(wèn)題。據(jù)估計(jì),每年有超過(guò)5千萬(wàn)至1億人感染登革熱病毒。隨著其宿主埃及伊蚊和白紋伊蚊棲息地的擴(kuò)張,全球面臨越來(lái)越嚴(yán)重的登革感染風(fēng)險(xiǎn)。四型登革病毒中每一型單獨(dú)感染均能導(dǎo)致一系列程度不一的臨床癥狀,從自限性的登革熱(DF)至危及生命的登革出血熱(DHF)或登革休克綜合癥(DSS)等重癥形式�；谂R床觀察,二次異型感染或登革患者胎兒隨年齡增長(zhǎng)均顯著增加重癥感染幾率,抗體依賴增強(qiáng)假說(shuō)(ADE)被提出以解釋登革病毒重癥感染病理機(jī)制。該理論認(rèn)為,在二次異型登革病毒感染中預(yù)先存在的交叉抗體能夠與病毒結(jié)合,通過(guò)抗體與靶細(xì)胞表面Fc受體的相互作用促進(jìn)病毒對(duì)單核細(xì)胞,巨噬細(xì)胞,以及成熟DC細(xì)胞的感染。目前研究認(rèn)為DENV-ADE能夠通過(guò)抑制Ⅰ型干擾素產(chǎn)生及效應(yīng)進(jìn)而促進(jìn)病毒增殖；其中抗炎癥細(xì)胞因子,如IL-10等對(duì)干擾素途徑的抑制作用在DENV-ADE感染中扮演的重要角色。然而有研究證明DENV-ADE感染的人初始單核細(xì)胞并不抑制干擾素或IL-10表達(dá)。這些研究顯示DENV-ADE感染Fc受體陽(yáng)性細(xì)胞存在一種更為普遍的機(jī)制,且不依賴于上調(diào)IL-10對(duì)一型干擾素抑制過(guò)程。在本研究中,我們使用Ⅰ型干擾素缺陷細(xì)胞K562建立了DENV3抗體依賴增感染體外模型,并體現(xiàn)出內(nèi)部增強(qiáng)感染形式。通過(guò)檢測(cè)抗病毒基因NOS2表達(dá)水平,發(fā)現(xiàn)DENV-ADE感染細(xì)胞中降低的NOS2表達(dá)及NO活性分子釋放導(dǎo)致了病毒胞內(nèi)復(fù)制增加。進(jìn)一步分析NOS2基因上游調(diào)控途徑,發(fā)現(xiàn)DENV-ADE感染中下調(diào)的NOS2基因表達(dá)源于固有免疫RIG-I/MDA-5—NF-κB—IRF-1信號(hào)途徑抑制。過(guò)表達(dá)RIG-I和/或MDA-5能夠協(xié)同促進(jìn)NF-κB活化及NOS2表達(dá)。為驗(yàn)證免疫抑制因子IL-10在DENV-ADE固有免疫抑制中的作用,我們檢測(cè)了IL-10/IL-6—SOCS3通路,發(fā)現(xiàn)DENV-ADE感染K562細(xì)胞未顯著上調(diào)IL-10, IL-6, SOCS3表達(dá)。利用CRISP/CAS9技術(shù)獲得IL-10敲出的K562細(xì)胞進(jìn)行DENV-ADE模型表明,IL-10并不影響DENV-ADE感染。由于細(xì)胞自噬過(guò)程在DENV復(fù)制中扮演重要作用,我們比較了DENV直接感染與DENV-ADE感染中自噬程度差異。研究發(fā)現(xiàn),DENV-ADE感染K562細(xì)胞誘導(dǎo)更高水平的自噬體形成及自噬相關(guān)蛋白ATG5, ATG12表達(dá)。通過(guò)藥物促進(jìn)或抑制細(xì)胞自噬進(jìn)程能夠劑量依賴性地促進(jìn)或抑制胞內(nèi)病毒復(fù)制,且完全敲除自噬相關(guān)蛋白ATG5顯著抑制胞內(nèi)病毒復(fù)制。結(jié)果表明,DENV-ADE感染通過(guò)誘導(dǎo)更強(qiáng)的自噬進(jìn)而促進(jìn)胞內(nèi)病毒增殖。此外,過(guò)表達(dá)自噬蛋白ATG5能夠通過(guò)抑制NF-κB活化及NOS2表達(dá)從而促進(jìn)病毒增殖。本研究發(fā)現(xiàn)DENV-ADE感染中病毒復(fù)制增強(qiáng)是由RIG-I/MDA-5—NF-κB— IRF-1—NOS2固有免疫途徑抑制導(dǎo)致的,且該抑制過(guò)程不依賴于IL-10—SOCS3對(duì)干擾素途徑的抑制。此外DENV-ADE感染能夠通過(guò)上調(diào)細(xì)胞自噬進(jìn)程,抑制固有免疫途徑,從而促進(jìn)病毒增殖。該研究將有助于加深我們對(duì)DENV-ADE感染機(jī)制的理解,并為重癥登革患者治療提供了理論支持和潛在靶點(diǎn),同時(shí)也表明自噬抑制劑在治療DENV-ADE引起的重癥登革熱疾病,以及抑制病毒胞內(nèi)復(fù)制方面具有潛在的應(yīng)用價(jià)值。
[Abstract]:Dengue virus (Dengue virus DENV) is a mosquito borne virus, in more than more than 100 countries, especially in Asia and Latin America, causing a major public health problem. It is estimated that there are more than 50 million to 100 million people infected with dengue virus each year. With its host Egypt and Iraq mosquito Aedes albopictus habitat expansion the world, facing increasingly serious risk of dengue infections. Dengue virus type four in each type of single infection can cause a series of clinical symptoms in different degree, from self limited dengue fever (DF) to life-threatening dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) in form. Based on clinical observation, two patients with dengue infection or abnormal fetal age were significantly increased in severe infection, antibody dependent enhancement hypothesis (ADE) is proposed to explain the dengue virus infection. The pathological mechanism of theory in the two different Dengue virus infection cross pre-existing antibodies can bind to the virus and antibody through interaction with the target cell surface Fc receptor on monocyte macrophage to promote viral infection, and, mature DC cells. The present study suggests that DENV-ADE can inhibit type I interferon production and effect and promote the proliferation of virus; anti inflammation cytokines, such as inhibition of IL-10 on interferon pathway in DENV-ADE infection plays important role. However, studies have shown that the initial DENV-ADE infection of monocytes did not inhibit interferon or IL-10 expression. These studies showed the presence of a common infection mechanism of DENV-ADE Fc receptor positive cells, and does not depend on the up regulation of IL-10 inhibit the process of a type of interferon. In this study, we use the type I interferon deficient cells K562 established DENV3 antibody dependent enhancement of infection. Outside the model, and reflect the internal form of infection. Enhanced expression levels by detection of antiviral gene NOS2, found that the virus has led to increased release of intracellular replication molecule NOS2 expression cells decreased and the activity of NO DENV-ADE infection. Further analysis of NOS2 gene upstream regulatory pathways, found that DENV-ADE infection in down-regulation of NOS2 gene expression in innate immune RIG-I/MDA-5 NF- B - kappa IRF-1 signaling pathway inhibition. Overexpression of RIG-I and / or MDA-5 can synergistically promote NOS2 activation and expression of NF- kappa B. In order to verify the immunosuppressive factor IL-10 in innate immune suppression in DENV-ADE, we examined the IL-10/IL-6 SOCS3 pathway, found DENV-ADE infected K562 cells did not significantly up-regulated the expression of IL-10, IL-6, SOCS3 expression get out of IL-10. By using the technology of CRISP/CAS9 K562 cell DENV-ADE model showed that IL-10 did not affect DENV-ADE infection due to autophagy in DENV. Play an important role in replication, we compared the autophagy of DENV direct infection and DENV-ADE infection in difference. The study found that autophagy induced higher levels of DENV-ADE infected K562 cells and the formation of autophagy related protein ATG5, ATG12 expression. The drugs promote or inhibit autophagy process could dose dependently promote or inhibit virus replication in cells completely, and knockdown of autophagy related protein ATG5 significantly inhibited the virus replication in cells. The results showed that DENV-ADE infection induced by stronger autophagy and promote the proliferation of virus in the cells. Moreover, overexpression of autophagy protein ATG5 can inhibit NF- B activation and NOS2 expression to promote proliferation of virus. This study found that DENV-ADE infection enhanced virus replication is caused by RIG-I/MDA-5 - NF- - IRF-1 - NOS2 - B innate immune pathways inhibition, and the inhibition process does not depend on the IL-10 - SOCS3 of interferon The way to inhibit DENV-ADE infection. In addition to the upregulation of cell autophagy process, inhibition of innate immune pathways, thereby promoting proliferation of virus. The study will help to deepen our understanding of the mechanism of DENV-ADE infection, and to provide theoretical support and a potential target for treatment of patients with severe leather also shows that, in the treatment of DENV-ADE induced autophagy inhibitors the severe dengue disease has potential application value and inhibit viral intracellular replication.

【學(xué)位授予單位】：北京協(xié)和醫(yī)學(xué)院
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2015
【分類(lèi)號(hào)】：R392

【共引文獻(xiàn)】

相關(guān)期刊論文 前10條

1 何利娜;王升啟;;登革病毒抑制劑的研究進(jìn)展[J];國(guó)際藥學(xué)研究雜志;2013年01期

2 沈延飛;李志軍;鄭繼生;李敏靜;董雷;蔡宛如;;“肺腸同治”對(duì)急性肺損傷大鼠肺和大腸組織P38表達(dá)影響[J];浙江中醫(yī)藥大學(xué)學(xué)報(bào);2013年08期

3 闕雪梅;黃玉紅;孫明軍;;益生菌對(duì)炎癥性腸病的作用及機(jī)制[J];國(guó)際消化病雜志;2013年05期

4 熊金巧;彭惠;;TLR3與年齡相關(guān)性黃斑變性疾病的相關(guān)性[J];國(guó)際眼科雜志;2014年03期

5 云小樂(lè);董仕超;張威;謝基明;康鴻斌;王玉珍;;乳腺癌細(xì)胞中Rab7基因的克隆及序列分析[J];基因組學(xué)與應(yīng)用生物學(xué);2014年02期

6 馬鑫;李丹地;李秀萍;段招軍;;輪狀病毒感染相關(guān)受體的研究進(jìn)展[J];病毒學(xué)報(bào);2014年03期

7 胥少華;曾毅;;TLR激動(dòng)劑類(lèi)疫苗佐劑研究進(jìn)展[J];公共衛(wèi)生與預(yù)防醫(yī)學(xué);2014年03期

8 陳亞冰;蘭道亮;林寶山;黃Pr;黃勇;李鍵;;牦牛Toll樣受體5基因的克隆及序列分析[J];中國(guó)畜牧獸醫(yī);2014年07期

9 李靜;李小康;何雷;賈艷艷;余祖華;郁川;陳松彪;顏云飛;張春杰;程相朝;李銀聚;吳庭才;;細(xì)胞自噬與胞內(nèi)病原體感染相互作用的研究進(jìn)展[J];中國(guó)畜牧獸醫(yī);2014年09期

10 李夏瑩;黃曉冬;劉肅;;佐劑及其功能和作用機(jī)制[J];安徽農(nóng)業(yè)科學(xué);2015年02期

相關(guān)會(huì)議論文 前2條

1 何鵬;胡忠玉;;Toll樣受體研究進(jìn)展[A];2013年中國(guó)藥學(xué)大會(huì)暨第十三屆中國(guó)藥師周論文集[C];2013年

2 曹羽;洪輝華;楊s，

本文編號(hào)：1688841